Antonina Luca, Giulia Donzuso, Concetta D'Agate, Claudio Terravecchia, Calogero Cicero Edoardo, Giovanni Mostile, Giorgia Sciacca, Alessandra Nicoletti, Mario Zappia
{"title":"帕金森病的语言推理障碍。","authors":"Antonina Luca, Giulia Donzuso, Concetta D'Agate, Claudio Terravecchia, Calogero Cicero Edoardo, Giovanni Mostile, Giorgia Sciacca, Alessandra Nicoletti, Mario Zappia","doi":"10.1155/2022/3422578","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to assess verbal reasoning (VR) functioning in patients with Parkinson's disease (PD) and healthy controls (HCs).</p><p><strong>Methods: </strong>The non-demented PD patients and HCs matched by age and global cognition were enrolled in this study. VR was assessed with the verbal reasoning test (VRT), total score, and subsets.</p><p><strong>Results: </strong>Eighty-seven PD patients (51 men; mean age 63.8 ± 7.9 years) and 87 HCs (46 men; mean age 63.7 ± 8.0 years) were enrolled. At univariate analysis, PD patients presented a significantly lower score in the VRT subset classification (12.3 ± 2.1) than HCs (12.9 ± 1.7) with an odds ratio (OR) of 0.8 (95% confidence interval [CI] 0.70-0.98; <i>p</i> = 0.003). The strength of association was also confirmed at multivariate analysis (OR = 0.8, 95% CI 0.70-0.98; <i>p</i> = 0.003). Moreover, in PD patients, a statistically significant positive correlation was found between VRT-classification and MoCA scores (<i>r</i> = 0.330; <i>p</i> = 0.002).</p><p><strong>Conclusions: </strong>PD patients presented lower VR performance than HCs.</p>","PeriodicalId":50733,"journal":{"name":"Behavioural Neurology","volume":"2022 ","pages":"3422578"},"PeriodicalIF":2.7000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759383/pdf/","citationCount":"0","resultStr":"{\"title\":\"Verbal Reasoning Impairment in Parkinson's Disease.\",\"authors\":\"Antonina Luca, Giulia Donzuso, Concetta D'Agate, Claudio Terravecchia, Calogero Cicero Edoardo, Giovanni Mostile, Giorgia Sciacca, Alessandra Nicoletti, Mario Zappia\",\"doi\":\"10.1155/2022/3422578\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The aim of this study was to assess verbal reasoning (VR) functioning in patients with Parkinson's disease (PD) and healthy controls (HCs).</p><p><strong>Methods: </strong>The non-demented PD patients and HCs matched by age and global cognition were enrolled in this study. VR was assessed with the verbal reasoning test (VRT), total score, and subsets.</p><p><strong>Results: </strong>Eighty-seven PD patients (51 men; mean age 63.8 ± 7.9 years) and 87 HCs (46 men; mean age 63.7 ± 8.0 years) were enrolled. At univariate analysis, PD patients presented a significantly lower score in the VRT subset classification (12.3 ± 2.1) than HCs (12.9 ± 1.7) with an odds ratio (OR) of 0.8 (95% confidence interval [CI] 0.70-0.98; <i>p</i> = 0.003). The strength of association was also confirmed at multivariate analysis (OR = 0.8, 95% CI 0.70-0.98; <i>p</i> = 0.003). Moreover, in PD patients, a statistically significant positive correlation was found between VRT-classification and MoCA scores (<i>r</i> = 0.330; <i>p</i> = 0.002).</p><p><strong>Conclusions: </strong>PD patients presented lower VR performance than HCs.</p>\",\"PeriodicalId\":50733,\"journal\":{\"name\":\"Behavioural Neurology\",\"volume\":\"2022 \",\"pages\":\"3422578\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759383/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Behavioural Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2022/3422578\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavioural Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2022/3422578","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Verbal Reasoning Impairment in Parkinson's Disease.
Background: The aim of this study was to assess verbal reasoning (VR) functioning in patients with Parkinson's disease (PD) and healthy controls (HCs).
Methods: The non-demented PD patients and HCs matched by age and global cognition were enrolled in this study. VR was assessed with the verbal reasoning test (VRT), total score, and subsets.
Results: Eighty-seven PD patients (51 men; mean age 63.8 ± 7.9 years) and 87 HCs (46 men; mean age 63.7 ± 8.0 years) were enrolled. At univariate analysis, PD patients presented a significantly lower score in the VRT subset classification (12.3 ± 2.1) than HCs (12.9 ± 1.7) with an odds ratio (OR) of 0.8 (95% confidence interval [CI] 0.70-0.98; p = 0.003). The strength of association was also confirmed at multivariate analysis (OR = 0.8, 95% CI 0.70-0.98; p = 0.003). Moreover, in PD patients, a statistically significant positive correlation was found between VRT-classification and MoCA scores (r = 0.330; p = 0.002).
Conclusions: PD patients presented lower VR performance than HCs.
期刊介绍:
Behavioural Neurology is a peer-reviewed, Open Access journal which publishes original research articles, review articles and clinical studies based on various diseases and syndromes in behavioural neurology. The aim of the journal is to provide a platform for researchers and clinicians working in various fields of neurology including cognitive neuroscience, neuropsychology and neuropsychiatry.
Topics of interest include:
ADHD
Aphasia
Autism
Alzheimer’s Disease
Behavioural Disorders
Dementia
Epilepsy
Multiple Sclerosis
Parkinson’s Disease
Psychosis
Stroke
Traumatic brain injury.